MaaT Pharma develops microbiome-based medicines for serious diseases. Its products and services focus on microbiome therapies for cancer care and related conditions, serving hospitals, doctors, and patients.
MaaT Pharma products and services overview:
Revenue: ~$3 million
Employees: 120
Headquarters: Lyon, France
MaaT Pharma is one of the...
MaaT Pharma is a company listed under the stock ticker MAAT (FR).
View the org chart displaying its 21 main executives
Create your alert
to follow the executive moves at MaaT Pharma.
MaaT Pharma has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.